VWF cleaving protease activity and inhibitors in patients with thrombotic thrombocytopenic purpura (TTP) treated with INTERCEPT FFP vs. conventional FFP: results of a phase III trial

• Conlan MGC ;
• Corash L ;
• Lin JS ;
• Mintz PD ;
• Neff AT ;
• Malcolm MR ;
• Hillyer CD ;
• Goodnough LT, ;
• et al.,